Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
4-2-1|Qu0-Th 0,n/a|Sequence:1, Age:92,Type:none (controls),Quantity:0,Unit:unit code not relevant,Application:not applicable or not supplied, Remarks:control|90 (0 in ERA)|Rat|Rat Wistar|Female|Young Adult|Serial sacrifice 0, 6, 12, 24 months after exposure and lifespan microscopic/macroscopic pathology|No information on individuals available for this study
4-2-2|Qu6-Th 0,n/a|Sequence:1, Age:92,Type:quartz,Quantity:6,Unit:milligram per cubic m,Application:Inhalation, Remarks:over a period of 29 days|90 (0 in ERA)|Rat|Rat Wistar|Female|Young Adult|Serial sacrifice 0, 6, 12, 24 months after exposure and lifespan microscopic/macroscopic pathology|No information on individuals available for this study
4-2-3|Qu30-Th 0,n/a|Sequence:1, Age:92,Type:quartz,Quantity:30,Unit:milligram per cubic m,Application:Inhalation, Remarks:over a period of 29 days|90 (0 in ERA)|Rat|Rat Wistar|Female|Young Adult|Serial sacrifice 0, 6, 12, 24 months after exposure and lifespan microscopic/macroscopic pathology|No information on individuals available for this study
4-2-4|Qu6-Th 600,n/a|Sequence:1, Age:92,Type:Th-228 colloid,Quantity:1065,Unit:becquerels per animal,Application:Injection, intravenous, Remarks:n/a|90 (0 in ERA)|Rat|Rat Wistar|Female|Young Adult|Serial sacrifice 0, 6, 12, 24 months after exposure and lifespan microscopic/macroscopic pathology|No information on individuals available for this study
4-2-4|Qu6-Th 600,n/a|Sequence:2, Age:92,Type:quartz,Quantity:6,Unit:milligram per cubic m,Application:Inhalation, Remarks:over a period of 29 days|90 (0 in ERA)|Rat|Rat Wistar|Female|Young Adult|Serial sacrifice 0, 6, 12, 24 months after exposure and lifespan microscopic/macroscopic pathology|No information on individuals available for this study
4-2-5|Qu30-Th 600,n/a|Sequence:1, Age:92,Type:Th-228 colloid,Quantity:1065,Unit:becquerels per animal,Application:Injection, intravenous, Remarks:n/a|90 (0 in ERA)|Rat|Rat Wistar|Female|Young Adult|Serial sacrifice 0, 6, 12, 24 months after exposure and lifespan microscopic/macroscopic pathology|No information on individuals available for this study
4-2-5|Qu30-Th 600,n/a|Sequence:2, Age:92,Type:quartz,Quantity:30,Unit:milligram per cubic m,Application:Inhalation, Remarks:over a period of 29 days|90 (0 in ERA)|Rat|Rat Wistar|Female|Young Adult|Serial sacrifice 0, 6, 12, 24 months after exposure and lifespan microscopic/macroscopic pathology|No information on individuals available for this study
4-2-6|Q0Th 600,n/a|Sequence:1, Age:92,Type:Th-228 colloid,Quantity:1065,Unit:becquerels per animal,Application:Injection, intravenous, Remarks:n/a|90 (0 in ERA)|Rat|Rat Wistar|Female|Young Adult|Serial sacrifice 0, 6, 12, 24 months after exposure and lifespan microscopic/macroscopic pathology|No information on individuals available for this study
		
